Programmed cell death and caspase-12

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/57 (2006.01) C07H 21/00 (2006.01) C07K 14/47 (2006.01) C12N 9/50 (2006.01) C12N 15/63 (2006.01)

Patent

CA 2402599

This invention relates to nucleic aids according caspase-12, proteins encoded by camp-12 nucleic acids proteins, and hosts transformed with vectors. Caspase-12 is a member of the caspase family, which also includes mammalian interleukin-1.beta.-converting enzyme (ICE). Caspases are thought to carry out the execution phase of apoptosis in a cascade of proteolytic events. The invention also to the use of caspsae-12 to induce programmed cell death.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Programmed cell death and caspase-12 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Programmed cell death and caspase-12, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Programmed cell death and caspase-12 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1860859

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.